Research area
Cancer Treatment
Cancer treatment strategies, radiation and precision treatment selection. Use the more specific immunotherapy, cell therapy or drug-delivery category when that is the central subject.
-
Evidence date ·Why do different tumors need different treatments after hormone-blocking therapy?
Review or Meta-AnalysisAn April 2026 review compares DNA repair, PSMA-targeted radiation and immune approaches for advanced prostate cancer. Their evidence comes from different kinds of studies.
-
Evidence date ·How tumor signals guide lung cancer treatment—and why the match can change
Review or Meta-AnalysisA 2025 review explains how lung tumors resist targeted drugs, what blood tests may detect, and why proposed combinations still need careful testing.
-
Evidence date ·How researchers are exploring different routes to tailored cancer treatment
Review or Meta-AnalysisA review surveys molecular, immune and gene-expression approaches to cancer therapy. It does not show whether matching a treatment to a patient improves outcomes.
-
Evidence date ·How drug carriers and immune treatments might address hard-to-treat digestive cancers
Review or Meta-AnalysisA 2025 review describes drug carriers and immune treatments being explored for digestive cancers. Their value for patients depends on clinical effectiveness and toxicity.
-
Evidence date ·How could engineered bacteria target colorectal cancer safely?
Review or Meta-AnalysisA 2024 review explains how phages, bacteria, and gene editing might reach colorectal tumors, while safety and patient benefit remain unproven.
-
Evidence date ·How might treatment be ordered for advanced basosquamous skin cancer?
Review or Meta-AnalysisFive clinical cases and a literature review suggest a drug sequence for advanced basosquamous skin cancer, but do not establish which order works best.
-
Evidence date ·Why clearing chemotherapy-stilled cells might matter in prostate cancer
Peer-Reviewed PaperIn mouse and cell models, ABT-263 reduced IL-20-linked signals after docetaxel; whether this can help patients remains untested.
-
Evidence date ·Why researchers may induce senescence before clearing cancer cells
Review or Meta-AnalysisA 2025 review explains how treatment-induced senescence reshapes tumor tissue, why senolytics differ from signal-modifying drugs, and what remains unproven.
-
Evidence date ·Why cells left in growth arrest after cancer therapy may become treatment targets
Review or Meta-AnalysisA review of 36 animal studies explains how targeting cells left after cancer therapy affects tumor size and survival—and why some combinations fail.